Home › Funds › Samsara BioCapital, LLC › ARTV

Samsara BioCapital, LLC position in ARTV

ARTIVA BIOTHERAPEUTICS INC · Health Care

Samsara BioCapital, LLC reported holding 954,861 shares of ARTV (ARTIVA BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.8M, representing 0.65% of its reported portfolio and ranking #19 among its reported holdings. Samsara BioCapital, LLC has disclosed ARTV holdings in 6 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)954.86K sh
Reported value held$6.80M
Portfolio Weight0.65%
First reportedQ3 2024
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Samsara BioCapital, LLC's ARTV position evolved

Samsara BioCapital, LLC first disclosed a stake in ARTV in Q3 2024 at 291,666 shares (US$4.5M). The position peaked in Q2 2026 at 954,861 shares, worth US$9.3M. Across 6 filings, Samsara BioCapital, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 954,861 shares valued at US$6.8M.

Quarter by quarter

QuarterSharesValueChange
Q3 2024 291.67K $4.51M New
Q4 2024 291.67K $2.94M Hold
Q1 2025 291.67K $875.00K Hold
Q2 2025 291.67K $440.42K Hold
Q2 2026 954.86K $9.26M New
Q3 2026 954.86K $6.80M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARTV and 13F data

ARTV (ARTIVA BIOTHERAPEUTICS INC) is a Health Care company. 87 other funds we track also report a position in ARTV — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$220.2M), 5AM Venture Management, LLC (US$139.1M), Deep Track Capital, LP (US$73.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARTV

All ARTV fund holders →

FAQ

How long has Samsara BioCapital, LLC held ARTV?

Samsara BioCapital, LLC has disclosed ARTV holdings in 6 of the last 9 reported quarters, going back to Q3 2024.

What is Samsara BioCapital, LLC's current position in ARTV?

As of Q3 2026, Samsara BioCapital, LLC holds 954.86K shares of ARTV (ARTIVA BIOTHERAPEUTICS INC), valued at $6.80M, representing 0.65% of its reported portfolio and ranking #19.

Has Samsara BioCapital, LLC been buying or selling ARTV?

In the latest 13F filing (Q3 2026), Samsara BioCapital, LLC held unchanged its position in ARTV. The position peaked in Q2 2026 at 954.86K shares.

Which other funds hold ARTV?

Other major institutional holders of ARTV include RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, Deep Track Capital, LP, among 87 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.